Home
Conditions
Immune Checkpoint Inhibitor

Clinical trial condition

Immune Checkpoint Inhibitor

Explore clinical trials studying Immune Checkpoint Inhibitor. Study availability and eligibility vary by location and protocol.

25 public trials 15 recruiting studies

Refine in advanced search Browse all conditions

Immune Checkpoint Inhibitor trial results

Recruiting

Safety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer

NCT06197581

Conditions: Breast Cancer, Familial Male, Breast Diseases, Breast Neoplasms, +11 more
Locations: Cancer Hospital ,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Toripalimab Plus FLOT in Locally Advanced Gastric Cancer

NCT04891016

Conditions: Chemotherapy, Immune Checkpoint Inhibitor, Locally Advanced Gastric Carcinoma
Locations: Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital Zhengzhou, Henan, China

View Trial Details

Recruiting

LAG3 Expression in Triple Negative Breast Cancer

NCT06259162

Conditions: Breast Diseases, Breast Neoplasms, Immune Checkpoint Inhibitor, +6 more
Locations: Ji-Yeon Kim Seoul, South Korea

View Trial Details

Recruiting

COVID-19 Vaccine Effectiveness Against Recurrent Infection Among Lung Cancer Patients and Biomarker Research

NCT06168032

Conditions: Antibody, COVID-19 Recurrent, Chemotherapy, +10 more
Locations: Peking Union Medical College Hospital Beijing, China

View Trial Details

Recruiting

Fast-Track Cardiovascular Assessment for Suspicion of Cardiovascular Events on Immunecheckpoint Inhibitors

NCT05799898

Conditions: Cancer, Cardiovascular Complication, Immune Checkpoint Inhibitor, +2 more
Locations: Intitut Mutualiste Montsouris Paris, France

View Trial Details

Not Yet Recruiting

Adjuvant Anti-PD-1 Therapy in Resected Hepatocellular Carcinoma

NCT07379489

Conditions: Adjuvant Therapy, Disease Attributes, HCC, +4 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

PRaG-1 Plus PRaG Therapy in Advanced Solid Tumors: A Prospective Clinical Trial (PRaG 10.0)

NCT07267234

Conditions: Cytopenia, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Study on the Relationship Between Opioid Drugs and the Therapeutic Efficacy of Immunotherapy

NCT07188857

Conditions: Agnosia, Immune Checkpoint Inhibitor, Nervous System Diseases, +7 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Prospective Study of Pembrolizumab Combining Chemotherapy in Advanced NSCLC Patients With EGFR Exon 21 Point Mutation.

NCT06142617

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: Peking Union Medical College Hospital Beijing, China

View Trial Details

Not Yet Recruiting

A Pilot Study to Understand the Impact of Therapy With Tumour Treating Fields (TTFields) in NSCLC

NCT05698264

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: Shaare Zedek Medical Center Jerusalem, Israel

View Trial Details

Immune Checkpoint Inhibitor

Immune Checkpoint Inhibitor trial results

Related conditions